Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406055 · ClinicalTrials.gov registry record
CHOICE: Carotid Stenting For High Surgical-Risk Patients
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 18,855
- Enrollment target
NCT00406055: Completed study, sponsored by Abbott Medical Devices.
NCT00406055 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 18,855 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00406055 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 18,855 participants
- Enrollment target
Study Summary
The purposes of this study is to 1) Provide additional information that the commercially available Abbott Vascular Carotid Stent Systems and Embolic Protection Systems can be used successfully by a wide range of physicians under commercial use conditions. 2) Provide an ongoing post-market surveillance mechanism for documentation of clinical outcomes and for possible extension of the Centers for Medicare and Medicaid Services (CMS) coverage to a broader group of patients.
Interventions
- DEVICE RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,855 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-06 |
What the finished NCT00406055 record still lists
NCT00406055 is an observational study that tracks outcomes without assigning an intervention. Its 18,855 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 is the first listed.
NCT00406055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00406055 about?
NCT00406055 is a clinical study titled "CHOICE: Carotid Stenting For High Surgical-Risk Patients". The purposes of this study is to 1) Provide additional information that the commercially available Abbott Vascular Carotid Stent Systems and Embolic Protection Systems can be used successfully by a wide range of physicians under commercial use conditions. 2) Provide an ongoing post-market surveillan...
What is the current status of trial NCT00406055?
This trial is currently completed. The enrollment target is 18,855 participants. The study started on 2006-10. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00406055?
The interventions under investigation include: RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 (DEVICE).
Who is sponsoring clinical trial NCT00406055?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia